Relative to athymic mice inoculated with NC cells, those inoculated with shELAVL1 cells exhibited a reduced tumor burden (Figure 7j–n), intimating that ELAVL1 may potentiate cisplatin resistance. The gene discussed is ELAVL1; the disease is neoplasm.